Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(2.07)
# 3,020
Out of 4,996 analysts
346
Total ratings
38.39%
Success rate
-5.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $61.67 | +29.72% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $73.75 | +1.69% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $64.09 | +1.42% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.05 | +245.68% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $40.66 | +145.94% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $15.20 | +196.05% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $33.37 | +124.75% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $12.97 | +131.30% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $20.95 | +110.02% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $18.36 | -45.53% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $12.83 | -22.06% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $16.31 | +83.94% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $16.93 | +638.33% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $10.80 | +38.89% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.14 | +338.60% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $6.10 | -18.03% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.90 | +72.41% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $6.77 | +121.57% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $17.82 | +152.53% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $3.24 | -7.41% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $9.26 | +331.97% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.55 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $2.29 | +205.68% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $2.41 | +24.48% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.51 | +292.85% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.48 | +1,775.00% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.44 | +175.74% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.29 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $0.84 | +72,223,437.77% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.26 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $61.67
Upside: +29.72%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $73.75
Upside: +1.69%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $64.09
Upside: +1.42%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.05
Upside: +245.68%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $40.66
Upside: +145.94%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $15.20
Upside: +196.05%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $33.37
Upside: +124.75%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $12.97
Upside: +131.30%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $20.95
Upside: +110.02%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $18.36
Upside: -45.53%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $12.83
Upside: -22.06%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $16.31
Upside: +83.94%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $16.93
Upside: +638.33%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $10.80
Upside: +38.89%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.14
Upside: +338.60%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $6.10
Upside: -18.03%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.90
Upside: +72.41%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $6.77
Upside: +121.57%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $17.82
Upside: +152.53%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $3.24
Upside: -7.41%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $9.26
Upside: +331.97%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.55
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $2.29
Upside: +205.68%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $2.41
Upside: +24.48%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.51
Upside: +292.85%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.48
Upside: +1,775.00%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.44
Upside: +175.74%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $0.84
Upside: +72,223,437.77%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $5.26
Upside: -